CURAIZON

Next Generation Zero-Touch Technology.

Do you forget to take your medication?

Curaizon is revolutionising the way patients manage their medications by combining advanced technology with a deep commitment to improving health outcomes. Their innovative platform empowers patients to stay on track with their treatment plans, reducing missed doses and enhancing adherence. By fostering better medication management, Curaizon not only improves individual health but also contributes to advancing medical research and driving meaningful insights for healthcare providers.

Curaizon’s solution integrates seamlessly with healthcare systems, ensuring a patient-centric approach that reduces clinical demand and delivers measurable value to both patients and providers. At 8th Fund, we are proud to support Curaizon in their mission to make healthcare more efficient, accessible, and impactful for all.

Improved Patient
Health Outcomes

Boosts patient health through better adherence.

Cost Saving

Cuts healthcare costs by preventing complications.

Insightful
Data

Delivers real-time data for medical research.

Efficient
Resources

Reduces emergency demand, optimizing care.

Our Story

Route to Market

Efficient and Accessible Distribution

Curaizon’s route to market focuses on partnerships with healthcare providers, insurers and pharmaceutical companies. By integrating into care pathways, collaborating on cost-saving initiatives, and leveraging digital marketing, Curaizon drives adoption, improves patient outcomes and creates value through actionable adherence data for research and healthcare optimisation.

Growth

Market Penetration

Curaizon taps into a €600 billion global market, addressing medication non-adherence among 4.3 billion people with chronic diseases. We’ll launch in key markets (Denmark, UK, Germany, Spain, USA) within three years, with Canada and Australia via White Label partners. Revenue will come from licensing, notifications and data monetisation.

The Why

Instantly Accessible to All.

We are committed to improving patient outcomes by tackling medication non-adherence, a leading cause of preventable hospitalisations and worsened health.

With more than 50% of the global population suffering from chronic conditions, our mission is to enhance medication adherence through our own innovation of zero-touch technology. Adoption will be seamless and instantly delivered to all patients within the healthcare system, reducing healthcare costs and advancing global health outcomes.

Funding Round

Fundraise for £10M

We are seeking a £10 million investment to accelerate the growth of Curaizon. This funding will enable us to expand our technology platform, scale our operations across key international markets, and enhance our data-driven solutions. With this investment, we aim to drive widespread adoption, improve patient outcomes, and solidify our position as a leader in medication adherence technology.

Investor Invite #2